Niche-modulated and niche-modulating genes in bone marrow cells

Blood Cancer Journal

Volumn 2, Issue 12, 2012, Pages

  Cohen, Y ^a   Garach Jehoshua, O ^a   Bar Chaim, A ^a   Kornberg, A ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

contactless gene signature; gene expression profile; leukemia; myeloma; niche modulated genes; niche modulating genes

Indexed keywords

ANGIOGENIC FACTOR; SCLEROPROTEIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CELL EXPANSION; CELL FRACTIONATION; CELL HOMING; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL;

EID: 84871099893     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2012.42     Document Type: Article

References (40)

1. Yaccoby S, Barlogie B, Epstein J. Primary myeloma cells growing in SCID-hu mice: a model for studying the Biology and treatment of myeloma and its manifestations. Blood 1998; 92: 2908-2913 (Pubitemid 28469106)
2. Nefedova Y, Landowski TH, Dalton WS. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms. Leukemia 2003; 17: 1175-1182 (Pubitemid 36722250)
3. Kohlmann A, Bullinger L, Thiede C, Schaich M, Schnittger S, Do? hner K et al. Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways. Leukemia 2010; 24: 1216-1220
4. Mahtouk K, Hose D, De Vos J, Moreaux J, Jourdan M, Rossi JF et al. Input of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applications. Clin Cancer Res 2007; 13: 7289-7295
5. Bergsagel PL, Kuehl WM, Zhan F. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 2005; 106: 296-303 (Pubitemid 40967205)
6. Zhan F, Huang Y, Colla S. The molecular classification of multiple myeloma. Blood 2006; 108: 2020-2028 (Pubitemid 44395016)
7. Zhan F, Hardin J, Kordsmeier B. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 2002; 99: 1745-1757 (Pubitemid 34533050)
8. Munshi NC, Hideshima T, Carrasco D. Identification of genes modulated in multiple myeloma using genetically identical twin samples. Blood 2004; 103: 1799-1806 (Pubitemid 38268976)
9. Mahtouk K, Hose D, Raynaud P. Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma. Blood 2007; 109: 4914-4923 (Pubitemid 46827789)
10. Shan Y, Carlock LR, Walker PD. NMDA receptor overstimulation triggers a prolonged wave of immediate early gene expression: relationship to excitotoxicity. Exp Neurol 1997; 144: 406-415 (Pubitemid 27224567)
11. Cohen Y, Hardan Y, Nagler A, Zipori D. Establishment of an in vitro culture method for multiple myeloma cells Blood (ASH Ann Meet Abs) 2004, Abstract no. 4878
12. Cohen y, Zipori D. Extremely peculiar nuclear changes in cultured primary myeloma cells, including bulging and duplication/multiplication of nuclei and cell expansion without apparent mitotic forms Blood (ASH Annu Meet Abs) 2004, Abstract no. 4879
13. Nie Y, Waite J, Brewer F, Sunshine MJ, Littman DR, Zou YR. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J Exp Med 2004; 200: 1145-1156 (Pubitemid 39507054)
14. Han SB, Moratz C, Huang NN, Kelsall B, Cho H, Shi CS et al. Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles. Immunity 2005; 22: 343-354 (Pubitemid 40387476)
15. Allende ML, Tuymetova G, Lee BG, Bonifacino E, Wu YP, Proia RL. S1P1 receptor directs the release of immature B cells from bone marrow into blood. J Exp Med 2010; 207: 1113-1124
16. Mahtouk K, Hose D, Re'me T, De Vos J, Jourdan M, Moreaux J et al. Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells. Oncogene 2005; 24: 3512-3524
17. Muller-Decker K, Furstenberger G. The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis. Mol Carcinog 2007; 46: 705-710 (Pubitemid 47255191)
18. Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 2002; 8: 289-293 (Pubitemid 34250108)
19. Aherne CM, McMorrow J, Kane D, FitzGerald O, Mix KS, Murphy EP. Identification of NR4A2 as a transcriptional activator of IL-8 expression in human inflammatory arthritis. Mol Immunol 2009; 46: 3345-3357
20. Mizukami Y, Jo WS, Duerr EM, Gala M, Li J, Zhang X et al. Induction of interleukin-8 preserves the angiogenic response in HIF-1 deficient colon cancer cells. Nat Med 2005; 11: 992-997 (Pubitemid 41294446)
21. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM et al. Interleukin- 8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798-1801
22. Zhao D, Desai S, Zeng H. VEGF stimulates PKD-mediated CREB-dependent orphan nuclear receptor Nurr1 expression: role in VEGF-induced angiogenesis. Int J Cancer 2011; 128: 2602-2612
23. Rangel J, Nosrati M, Leong SP, Haqq C, Miller 3rd JR, Sagebiel RW et al. Novel role for RGS1 in melanoma progression. Am J Surg Pathol 2008; 32: 1207-1712
24. Boelte KC, Gordy LE, Joyce S, Thompson MA, Yang L, Lin PC. Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1 PLoS One 2011; 6: e18534
25. Mahtouk K, Cremer FW, Re'me T, Jourdan M, Baudard M, Moreaux J et al. Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma. Oncogene 2006; 25: 7180-7191 (Pubitemid 44764187)
26. Willmarth NE, Ethier SP. Amphiregulin as a novel target for breast cancer therapy. J Mammary Gland Biol Neoplasia 2008; 13: 171-179
27. Behrens A, Sibilia M, David JP, Mo? hle-Steinlein U, Tronche F, Schu? tz G et al. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J 2002; 21: 1782-1790 (Pubitemid 34614634)
28. Li X, Tai HH. Activation of thromboxane A(2) receptors induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells. Carcinogenesis 2009; 30: 1606-1613
29. Yokoyama T, Nakamura T. Tribbles in disease: Signaling pathways important for cellular function and neoplastic transformation. Cancer Sci 2011; 102: 1115-1522
30. Gilby DC, Sung HY, Winship PR, Goodeve AC, Reilly JT, Kiss-Toth E. Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis. Blood 2007; 109: 3998-4005
31. Dussmann P, Pagel JI, Vogel S, Magnusson T, Zimmermann R, Wagner E et al. Live in vivo imaging of Egr-1 promoter activity during neonatal development, liver regeneration and wound healing. BMC Dev Biol 2011; 20: 28
32. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al. miR-15 and miR-16 induce apoptosis by targeting BCL2 Proc Natl Acad Sci USA 2005; 102: 13944-13949 (Pubitemid 41377683)
33. Preston GA, Lyon TT, Yin Y, Lang JE, Solomon G, Annab L et al. Induction of apoptosis by c-Fos protein. Mol Cell Biol 1996; 16: 211-218 (Pubitemid 126506966)
34. Baumann S, Hess J, Eichhorst ST, Krueger A, Angel P, Krammer PH et al. An unexpected role for FosB in activation-induced cell death of T cells. Oncogene 2003; 22: 1333-1339 (Pubitemid 36384594)
35. Podar K, Raab MS, Tonon G, Sattler M, Barila' D, Zhang J et al. Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma. Cancer Res 2007; 67: 1680-1688 (Pubitemid 46383394)
36. Chen L, Wang S, Zhou Y, Wu X, Entin I, Epstein J et al. Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma. Blood 2010; 115: 61-70
37. Joslin JM, Fernald AA, Tennant TR, Davis EM, Kogan SC, Anastasi J et al. Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Blood 2007; 110: 719-726 (Pubitemid 47105411)
38. Kharas MG, Yusuf I, Scarfone VM, Yang VW, Segre JA, Huettner CS. KLF4 suppresses transformation of pre-B cells by ABL oncogene. Blood 2007; 109: 747-755 (Pubitemid 46105977)
39. Gilby DC, Sung HY, Winship PR, Goodeve AC, Reilly JT, Kiss-Toth E. Tribbles-1 and - 2 are tumour suppressors, down-regulated in human acute myeloid leukaemia. Immunol Lett 2010; 130: 115-124
40. Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B et al. The role of the Wntsignaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 2003; 349: 2483-2494 (Pubitemid 38010074)